CD4 and neoplasm: CD4+CD25high Treg cells from cancer patients effectively inhibit NK cell-mediated cytotoxicity (Wolf et al., 2003) and the depletion of CD4+CD25+ Treg cells enhances NKT cell-mediated anti-tumor immunity in a murine mammary breast cancer model (Hong et al., 2010).